Nanolipidic particles improve the bioavailability and alpha-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer's disease.

Source:http://linkedlifedata.com/resource/pubmed/id/20083179

Int J Pharm 2010 Apr 15 389 1-2 207-12

Download in:

View as

General Info

PMID
20083179